Listed

SBC Medical Group Holdings Inc

SBCNasdaqCIK 1930313HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$49.2mRevenue, Q2 FY2026, three months to 2026-06-30$49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$49.2mRevenue, Q2 FY2026, three months to 2026-06-30$49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure+13.4% on a year earlier
  • Gross margin73.1%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $36.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure+3.9 pts on a year earlier
  • Operating margin38.5%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $19.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure+5.0 pts on a year earlier
  • Net margin21.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure+16.1 pts on a year earlier
  • Diluted EPS$0.10Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure+400.0% on a year earlier
  • Free cash flow$22.4mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $22.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347843. Derived: 6-month figure less the 3-month figure.Capital expenditure: $84.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347843. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$49.2mGross margin 73.1%
Diluted EPS$0.10, Q2 FY2026
Free cash flow$22.4m, Q2 FY2026
SBC Medical Group Holdings Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m53.1Revenue, Q3 FY2024, three months to 2024-09-30$53.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure44.4Revenue, Q4 FY2024, three months to 2024-12-31$44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure47.3Revenue, Q1 FY2025, three months to 2025-03-31$47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure43.4Revenue, Q2 FY2025, three months to 2025-06-30$43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure43.4Revenue, Q3 FY2025, three months to 2025-09-30$43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure39.6Revenue, Q4 FY2025, three months to 2025-12-31$39.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure43.1Revenue, Q1 FY2026, three months to 2026-03-31$43.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure49.2Revenue, Q2 FY2026, three months to 2026-06-30$49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure
Gross margin%81.5%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $43.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Revenue: $53.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure76.3%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $33.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Revenue: $44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure79.7%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $37.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure69.2%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $30.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure70.6%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $30.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Revenue: $43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure73.1%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $28.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Revenue: $39.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure70.5%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $30.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Revenue: $43.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure73.1%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $36.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure
Operating margin%26.1%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Revenue: $53.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure10.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Revenue: $44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure51.1%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure33.6%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $14.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure36.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $15.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Revenue: $43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure32.5%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Revenue: $39.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure41.2%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Revenue: $43.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure38.5%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $19.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure
Net margin%5.3%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Revenue: $53.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure14.7%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Revenue: $44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure45.4%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $21.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Revenue: $47.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure5.7%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure29.6%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Revenue: $43.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figure35.9%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Revenue: $39.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure26.3%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Revenue: $43.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure21.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Revenue: $49.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure
Diluted EPS$ per share0.03Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figurenot reported (Diluted EPS not reported)0.21Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure0.02Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure0.12Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-281466.Report this figurenot reported (Diluted EPS not reported)0.11Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure0.10Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-347843.Report this figure
Free cash flow$m4.6Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-281466. Derived: 9-month figure less the 6-month figure.Capital expenditure: $409.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001193125-25-281466. Derived: 9-month figure less the 6-month figure.Report this figure(7.9)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Capital expenditure: $590.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure1.7Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Capital expenditure: $253.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure(8.6)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347843. Derived: 6-month figure less the 3-month figure.Capital expenditure: $306.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347843. Derived: 6-month figure less the 3-month figure.Report this figure(20.9)Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$20.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-281466. Derived: 9-month figure less the 6-month figure.Capital expenditure: $43.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-14, accession 0001193125-25-281466. Derived: 9-month figure less the 6-month figure.Report this figure51.2Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $52.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Capital expenditure: $797.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001193125-26-127557. Derived: 12-month figure less the 9-month figure.Report this figure9.1Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Capital expenditure: $125.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222737.Report this figure22.4Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $22.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-347843. Derived: 6-month figure less the 3-month figure.Capital expenditure: $84.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-347843. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$173.6mGross margin 73.3%
Diluted EPS$0.50, FY2025
Free cash flow$23.3m, FY2025
SBC Medical Group Holdings Inc, key figures for the last five fiscal years
Line itemUnitFY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m194Revenue, FY2023, twelve months to 2023-12-31$193.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001641172-25-001062.Report this figure205Revenue, FY2024, twelve months to 2024-12-31$205.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure174Revenue, FY2025, twelve months to 2025-12-31$173.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure
Gross margin%70.9%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $137.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-28, accession 0001641172-25-001062.Revenue: $193.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001641172-25-001062.Report this figure76.0%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $156.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001193125-26-127557.Revenue: $205.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure73.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $127.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-27, accession 0001193125-26-127557.Revenue: $173.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure
Operating margin%36.5%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $70.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001062.Revenue: $193.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001641172-25-001062.Report this figure34.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $70.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557.Revenue: $205.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure38.9%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $67.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557.Revenue: $173.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure
Net margin%20.3%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $39.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001062.Revenue: $193.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001641172-25-001062.Report this figure22.7%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $46.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557.Revenue: $205.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure29.4%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $51.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001193125-26-127557.Revenue: $173.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure
Diluted EPS$ per share0.42Diluted EPS, FY2023, twelve months to 2023-12-31$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-28, accession 0001641172-25-001062.Report this figure0.48Diluted EPS, FY2024, twelve months to 2024-12-31$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure0.50Diluted EPS, FY2025, twelve months to 2025-12-31$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure
Free cash flow$m42.1Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $50.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001641172-25-001062.Capital expenditure: $8.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001641172-25-001062.Report this figure18.0Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $20.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001193125-26-127557.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure23.3Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $24.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001193125-26-127557.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001193125-26-127557.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding SBC Medical Group Holdings Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Lumbard & Kellner, LLC2026-06-30$5.3m1,727,208Added+1,709,935
BlackRock, Inc.2026-06-30$2.8m924,002Added+504,362
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$1.3m427,864Added+132,085
BOOTHBAY FUND MANAGEMENT, LLC2026-06-30$551.1k178,929Reduced−1,700
CITADEL ADVISORS LLC2026-06-30$445.7k144,718New+144,718
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$418.2k135,783Reduced−456
NORTHERN TRUST CORP2026-06-30$404.1k131,204Added+40,065
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$395.1k128,295Added+64,748
Hillsdale Investment Management Inc.2026-06-30$384.4k124,800New+124,800
SEGALL BRYANT & HAMILL, LLC2026-06-30$250.4k81,307Unchanged

Recent filings

All 232 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

SBC Medical Group Holdings Inc, recent filings
FiledFormWhat it isAccession number
2026-08-1307:00 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-347843
2026-08-1306:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-347825
2026-07-1417:00 ET8-K3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-26-033195
2026-05-2806:09 ETDEF 14AProxy statementPeriod 2026-05-280001493152-26-025514
2026-05-2016:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-26-024609
2026-05-1407:00 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-222737
2026-05-1406:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-222720
2026-04-3017:21 ET10-K/AAnnual report, amendedPeriod 2025-12-310001493152-26-020748
2026-04-2320:48 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-26-018603
2026-04-2121:07 ETSCHEDULE 13D/AOwnership report, active investor, amended0001493152-26-018402

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1930313
Tickers
SBC, SBCWW
Exchange
Nasdaq
SIC code
8011 Services-Offices & Clinics of Doctors of Medicine
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Former names
Pono Capital Two, Inc. (to 2024-08-29)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.